LCE2B and prostate adenocarcinoma: Pancancer analysis revealed that LCE2B was differentially expressed in normal and tumor tissues in HNSCC, lung adenocarcinoma, pancreatic adenocarcinoma, prostatic adenocarcinoma, and skin cutaneous melanoma (P< 0.05; Figure 13E).